JPH0565222A - Film containing pullulan blended therein for capsule and capsule - Google Patents

Film containing pullulan blended therein for capsule and capsule

Info

Publication number
JPH0565222A
JPH0565222A JP25704891A JP25704891A JPH0565222A JP H0565222 A JPH0565222 A JP H0565222A JP 25704891 A JP25704891 A JP 25704891A JP 25704891 A JP25704891 A JP 25704891A JP H0565222 A JPH0565222 A JP H0565222A
Authority
JP
Japan
Prior art keywords
capsule
pullulan
film
soft
blended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP25704891A
Other languages
Japanese (ja)
Inventor
Isao Sato
勲 佐藤
Takashi Kondo
隆 近藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuji Capsule Co Ltd
Original Assignee
Fuji Capsule Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Capsule Co Ltd filed Critical Fuji Capsule Co Ltd
Priority to JP25704891A priority Critical patent/JPH0565222A/en
Publication of JPH0565222A publication Critical patent/JPH0565222A/en
Withdrawn legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a soft capsule, capable of stably enclosing a readily oxidiza ble substance, exhibiting easy solubility and withstanding a production method according to a punching method by blending a capsule film substrate such as gelatin, agar or carrageenan with pullulan. CONSTITUTION:A film containing pullulan (natural neutral polysaccharides which contain maltotriose that is a trimer of glucose repeatedly bound through alpha-1,6-glucoside bonds and are useful as a food) blended therein for a capsule is obtained by blending a capsule film substrate such as gelatin, agar or carrageenan with the pullulan in an amount of about 5-10% based on the total weight of the film. A readily oxidizable substance such as eicopapentaenoic acid, docosahexaenoic acid or beta-carotene can stably be contained by using the film containing the blended therein to afford the capsule. The resultant capsule is excellent in solubility in the stomach and capable of rapidly exhibiting effect of the medicine. Even if a soft capsule is produced by a punching method such as a flat plate or rotary die, the bonded surface is firm and there is no fear of leaking liquid contents and breaking the bonded surface, etc., with time.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、医薬品、健康食品、化
粧品等に用いる軟カプセル剤又は硬カプセル剤を対象と
したカプセル剤用プルラン配合皮膜及びカプセル剤に関
する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a pullulan-containing film for capsules and a capsule for soft capsules or hard capsules used in pharmaceuticals, health foods, cosmetics and the like.

【0002】[0002]

【従来の技術】一般に、軟カプセル剤又は硬カプセル剤
の皮膜はゼラチン、寒天、カラギ−ナン等の水溶性皮膜
剤成分より形成されている。そして、軟カプセル剤は例
えばゼラチンと水、及び可塑剤からなる皮膜基剤をゲル
化して得た軟カプセル皮膜により、内容物を被包して製
造される。又、硬カプセル剤は例えばゼラチン水溶液を
型回りに付着させて乾燥させることによって成形した硬
カプセル皮膜内に内容物を充填することにより製造され
る。
2. Description of the Related Art In general, a film of a soft capsule or a hard capsule is formed of a water-soluble film agent component such as gelatin, agar and carrageenan. The soft capsule is manufactured by encapsulating the contents with a soft capsule film obtained by gelling a film base consisting of gelatin, water, and a plasticizer. Further, the hard capsule is produced by, for example, attaching an aqueous gelatin solution around the mold and drying the mixture to fill the content in the hard capsule film formed.

【0003】[0003]

【発明が解決しようとする課題】上記した従来のカプセ
ル剤用皮膜には下記の如き課題がある。 (1)一般に成人病の予防等に効果があると言われてい
るイコサペント酸(以下EPAと略称する)やドコサヘ
キサエン酸(以下DHAと略称する)あるいはβ−カロ
チン等は何れもその分子内に多くの二重結合を有するこ
とから、極めて酸化され易い物質である。しかも、これ
等の物質は特有の異味、異臭を有するために一般の食品
にそのままの形で配合することは出来ない。そこで、一
般に軟カプセル剤に封入した健康食品として用いられて
いる。又、軟カプセル剤に封入した後、食品に添加する
方法も公知である。(特開昭60−102138号、特
公昭60−66935号、特開平2−203741号)
しかし、これ等の方法では異味、異臭を覆うことは出来
るが、内容物の酸化を完全に防止することはできず、経
時的に過酸化物価が上昇してしまう問題があった。 (2)医薬品や健康食品に用いられるカプセル剤は一般
に摂取後、胃内で溶解性が良好で内容物が持つ薬効を速
やかに発現せしめることが要求されるため、カプセル剤
の溶解性を向上させることは元来カプセル剤の重要な課
題である。 (3)平板式、ロ−タリ−ダイ式等の打抜き法により軟
カプセル剤を製造するには、例えばゼラチンと水、及び
可塑剤からなる皮膜基剤をゲル化して得た2枚の軟カプ
セル皮膜の間に内容物を圧入しつつ金型で圧切すること
により皮膜同志を接着させて成形する。この時の皮膜の
接着性を高めることは軟カプセル剤の経時的安定性を向
上させる。即ち、内容物の液漏れ、接着面の割れ等を防
ぐ意味で軟カプセル剤の重要な課題である。しかして、
本発明ではEPA,DHA,β−カロチン等の極めて酸
化され易い物質を経時的な過酸化物価の上昇が少なく安
定に封入せしめたカプセル剤の提供を目的とする。又、
本発明は溶解性が良好で内容物が持つ薬効を速やかに発
現し得るカプセル剤の提供を目的とする。更に、本発明
は打ち抜き法により製造する軟カプセル剤の接着面を強
固にして経時的な内容物の液漏れ、接着面の割れ等が無
い軟カプセル剤の提供を目的とする。
The above-mentioned conventional capsule film has the following problems. (1) Many of icosapentaenoic acid (hereinafter abbreviated as EPA), docosahexaenoic acid (hereinafter abbreviated as DHA), β-carotene, and the like, which are generally said to be effective in preventing adult diseases, are included in the molecule. Since it has a double bond of, it is a substance that is extremely easily oxidized. Moreover, since these substances have peculiar off-tastes and off-flavors, they cannot be blended in ordinary foods as they are. Therefore, it is generally used as a health food enclosed in a soft capsule. Further, a method of encapsulating in a soft capsule and then adding to a food is also known. (JP-A-60-102138, JP-B-60-66935, JP-A-2-203741)
However, although these methods can cover the off taste and the offensive odor, they cannot completely prevent the oxidation of the contents and have a problem that the peroxide value increases with time. (2) Capsules used for pharmaceuticals and health foods generally have good solubility in the stomach after ingestion, and it is required that the drug effect possessed by the contents be promptly developed, so that the solubility of the capsules is improved. This is originally an important issue for capsules. (3) In order to produce a soft capsule by a punching method such as a flat plate method or a rotary die method, for example, two soft capsules obtained by gelling a film base consisting of gelatin, water and a plasticizer. The contents are pressed into the space between the films, and the molds are cut off to bond the films to each other for molding. Increasing the adhesiveness of the film at this time improves the stability of the soft capsule over time. That is, it is an important issue for soft capsules in the sense of preventing liquid leakage of contents and cracking of the adhesive surface. Then,
An object of the present invention is to provide a capsule in which substances that are extremely easily oxidized, such as EPA, DHA, and β-carotene, are stably encapsulated with little increase in peroxide value over time. or,
An object of the present invention is to provide a capsule having good solubility and capable of rapidly exhibiting the drug effect of the content. A further object of the present invention is to provide a soft capsule which is manufactured by a punching method so that the adhesive surface of the soft capsule is strengthened so that there is no liquid leakage of contents over time, cracking of the adhesive surface and the like.

【0004】[0004]

【課題を解決するための手段】本発明者らは、プルラン
の有する様々な性質に着目し、ゼラチン、寒天、カラギ
−ナン等のカプセル皮膜基剤にプルランを配合したもの
である。ここにプルランとはグルコ−スの3量体である
マルトトリオ−スがα−1,6グルコシド結合で繰り返
し結合した天然の中性多糖類であり、我国ではデンプン
同様、使用制限がない食品として認可されている。本発
明に於いては、例えば「プルランPF−20」の名称で
林原商事(株)より一般に市販されているものを用いる
ことができる。
The present inventors have focused on various properties of pullulan and have incorporated pullulan into a capsule film base such as gelatin, agar, and carrageenan. Here, pullulan is a natural neutral polysaccharide in which maltotriose, which is a glucose trimer, is repeatedly bound by α-1,6 glucoside bonds, and in Japan, like starch, it is approved as a food with no restrictions on use. Has been done. In the present invention, for example, a commercially available product from Hayashibara Shoji Co., Ltd. under the name "Pullulan PF-20" can be used.

【0005】前記したプルランのカプセル皮膜基剤への
配合量は、特に制限はないが、その配合量を増すほどカ
プセル剤皮膜の不透明化及びカプセル剤表面のつやの消
失が進行する。従って、好ましくは製造後のカプセル剤
の皮膜総重量の1%〜15%、特に好ましくは5%〜1
0%である。1%よりも少ないと本発明の何れの目的に
於いても効果が十分に発現されず、15%以上であれば
カプセル剤皮膜の不透明化及びカプセル剤表面のつやの
消失が著しい。然しながら、本発明の何れの目的に於い
ても、プルランの配合量が多いほど効果の発現が顕著に
現われる。
The amount of pullulan to be added to the capsule film base is not particularly limited, but as the amount of pullulan is increased, the capsule film becomes more opaque and the capsule surface loses its gloss. Therefore, it is preferably 1% to 15%, particularly preferably 5% to 1% of the total weight of the capsule film after production.
It is 0%. If it is less than 1%, the effect is not sufficiently exhibited for any purpose of the present invention, and if it is 15% or more, the capsule film becomes opaque and the surface of the capsule loses its gloss. However, for any of the purposes of the present invention, the greater the amount of pullulan compounded, the more remarkable the effect.

【0006】本発明のカプセル剤用プルラン配合皮膜や
カプセル剤を調製するには特別な手段は必要とせず、軟
カプセル剤1、硬カプセル剤ともに常法の皮膜液仕込方
法、カプセル製造方法を用いることが出来る。又、本発
明のうちカプセル剤の内容物2の酸化を防止する目的に
於いては、通常の皮膜処方で易酸化物質を封入したカプ
セル剤についてプルランの水溶液でコ−ティングする方
法も効果がある。
No special means is required to prepare the pullulan-containing film for capsules and capsules of the present invention, and both the soft capsule 1 and the hard capsule are prepared by a conventional method for preparing a coating solution and a capsule manufacturing method. You can Further, for the purpose of preventing the oxidation of the content 2 of the capsule in the present invention, a method of coating the capsule containing the easily oxidizable substance with an ordinary film formulation with an aqueous solution of pullulan is also effective. .

【0007】[0007]

【実施例】皮膜処方としてゼラチン100重量部、グリ
セリン30重量部、水100重量部から成る皮膜基剤に
プルラン10重量部を配合した。この配合物皮膜から軟
カプセル剤1の製法の1つである打抜き法のロ−タリ−
ダイ式製造法によりオ−バル5型(OVAL5型)の軟
カプセル剤1を製造した。プルランは、林原商事(株)
の「プルランPF−20」を採用した。又、内容液2は
精製イワシ油(過酸化物価0.1(meq/kg)(ミ
リ当量/kg)EPA含有量12.5%、DHA含有量
10.5%を用いた。
Example As a film formulation, 10 parts by weight of pullulan was added to a film base comprising 100 parts by weight of gelatin, 30 parts by weight of glycerin and 100 parts by weight of water. The rotary film of the punching method, which is one of the methods for producing the soft capsule 1 from this compound film.
Oval 5 type (OVAL 5 type) soft capsule 1 was produced by a die-type production method. Pullulan is Hayashibara Shoji Co., Ltd.
"Pullulan PF-20" of No. Further, as the content liquid 2, refined sardine oil (peroxide value 0.1 (meq / kg) (milliequivalent / kg) EPA content 12.5% and DHA content 10.5% was used.

【0008】(比較例)皮膜処方としてゼラチン100
重量部、グリセリン30重量部、水100重量部から成
る皮膜基剤を前述と同じ製法同じ内容液で軟カプセル剤
を製造した。要するに、プルランを配合してないもので
ある。
Comparative Example Gelatin 100 as a film formulation
A soft base capsule was manufactured by using the same content liquid as the above-mentioned manufacturing method with a film base comprising 1 part by weight, 30 parts by weight of glycerin, and 100 parts by weight of water. In short, it does not contain pullulan.

【0009】(実験1)前記実施例及び前記比較例の軟
カプセル剤について6号サンプルビンに50カプセルづ
つ採り、開栓状態にて、40℃の恒温槽に1週間保存し
た後、過酸化物価を測定し、保存前の値と比較した。そ
れを表1に示す。
(Experiment 1) 50 capsules of No. 6 sample bottle were taken for each of the soft capsules of the above-mentioned Examples and Comparative Examples, and stored in a thermostat bath at 40 ° C. for 1 week with the peroxide value. Was measured and compared with the value before storage. It is shown in Table 1.

【0010】[0010]

【表1】 [Table 1]

【0011】前記した表1により、実施例の軟カプセル
剤は比較例の軟カプセル剤に比べて内容物の過酸化物価
の上昇が少ない点で優れていた。
As shown in Table 1 above, the soft capsules of the examples were superior to the soft capsules of the comparative example in that the peroxide value of the contents was less increased.

【0012】(実験2)前記実施例及び前記比較例の軟
カプセル剤について各6カプセルづつ日本薬局方規定の
崩壊試験を行った。その結果を表2に示す。
(Experiment 2) The soft capsules of the above Examples and Comparative Examples were subjected to a disintegration test according to the Japanese Pharmacopoeia for each 6 capsules. The results are shown in Table 2.

【0013】[0013]

【表2】 [Table 2]

【0014】前記した表2より実施例の軟カプセル剤は
比較例の軟カプセル剤に比べて崩壊時間が短く、溶解性
が優れていた。
As shown in Table 2 above, the soft capsules of Examples were shorter in disintegration time and superior in solubility than the soft capsules of Comparative Example.

【0015】(実験3)前記実施例及び前記比較例の軟
カプセル剤の中心部を図1に示す如く切断し、実体顕微
鏡にてA〜D各々の部位の厚さを測定した。但し、A及
びBは接着部を示し、C及びDは皮膜部を示す。その測
定結果を表3に示す。
(Experiment 3) The central portions of the soft capsules of the above-mentioned Examples and Comparative Examples were cut as shown in FIG. 1, and the thickness of each portion A to D was measured with a stereoscopic microscope. However, A and B show an adhesion part, and C and D show a film part. The measurement results are shown in Table 3.

【0016】[0016]

【表3】 [Table 3]

【0017】前記した表3より、実施例の軟カプセル剤
は比較例の軟カプセル剤に比べて皮膜部の厚さは略同等
ながら、接着部の厚さは格段に厚かった。このことは実
施例の軟カプセル剤は比較例の軟カプセル剤に比べて接
着不良が起因する処の経時的な内容液の漏れ及びカプセ
ル剤の割れ等が生じる可能性が少ないことを示唆してい
る。
From Table 3 above, the soft capsules of the examples were substantially thicker in thickness than the soft capsules of the comparative example, while the thickness of the adhesive portion was significantly thicker. This suggests that the soft capsules of the examples are less likely to cause leakage of the content liquid and cracking of the capsules over time due to poor adhesion as compared with the soft capsules of the comparative examples. There is.

【0018】[0018]

【発明の効果】(1)本発明ではEPA,DHA,β−
カロチンのような易酸化性物質を、経時的な過酸化物価
の上昇が少なく安定に封入せしめたカプセル剤を得るこ
とが出来る。 (2)溶解性が良好で内容物が有する薬効を速やかに発
現し得るカプセル剤を得ることが出来る。 (3)打ち抜き法により製造する軟カプセル剤の接着面
を強固にし、経時的な内容物の液漏れ、接着面の割れ等
がない軟カプセル剤を得ることが出来る。
(1) In the present invention, EPA, DHA, β-
It is possible to obtain a capsule in which an easily oxidizable substance such as carotene is stably encapsulated with little increase in peroxide value over time. (2) It is possible to obtain a capsule having good solubility and capable of rapidly exhibiting the drug effect of the content. (3) It is possible to obtain a soft capsule which is produced by a punching method by strengthening the adhesive surface of the soft capsule, which is free from leakage of contents over time, cracking of the adhesive surface and the like.

【図面の簡単な説明】[Brief description of drawings]

【図1】図1はロ−タリ−ダイ式製造法により製造した
本発明に係る軟カプセル剤の縦断面図である。
FIG. 1 is a longitudinal sectional view of a soft capsule preparation according to the present invention manufactured by a rotary die manufacturing method.

【符号の説明】[Explanation of symbols]

1 軟カプセル剤 2 内容液 1 Soft capsule 2 Content liquid

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 皮膜基剤にプルランを配合することを特
徴とするカプセル剤用プルラン配合皮膜
1. A pullulan-containing film for capsules, characterized in that pullulan is added to the film base.
【請求項2】 プルラン配合皮膜によって易酸化性物質
の内容物を被包したカプセル剤
2. A capsule in which the content of an easily oxidizable substance is encapsulated by a pullulan-containing film.
【請求項3】 プルラン配合皮膜によって内容物を被包
した易溶解性のカプセル剤
3. An easily soluble capsule containing the contents encapsulated by a pullulan-containing film.
【請求項4】 プルラン配合皮膜によって内容物を被包
したカプセル剤であって、打ち抜き法により製造した強
固な接着面を有する軟カプセル剤
4. A capsule having a pullulan-containing film encapsulated therein, the soft capsule having a strong adhesive surface produced by a punching method.
JP25704891A 1991-09-09 1991-09-09 Film containing pullulan blended therein for capsule and capsule Withdrawn JPH0565222A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP25704891A JPH0565222A (en) 1991-09-09 1991-09-09 Film containing pullulan blended therein for capsule and capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25704891A JPH0565222A (en) 1991-09-09 1991-09-09 Film containing pullulan blended therein for capsule and capsule

Publications (1)

Publication Number Publication Date
JPH0565222A true JPH0565222A (en) 1993-03-19

Family

ID=17301016

Family Applications (1)

Application Number Title Priority Date Filing Date
JP25704891A Withdrawn JPH0565222A (en) 1991-09-09 1991-09-09 Film containing pullulan blended therein for capsule and capsule

Country Status (1)

Country Link
JP (1) JPH0565222A (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050095A1 (en) * 1999-02-26 2000-08-31 Warner-Lambert Company Bioadhesive antibacterial wound healing composition
EP1072633A1 (en) * 1999-07-22 2001-01-31 Warner-Lambert Company Pullulan film compositions
WO2001007507A1 (en) * 1999-07-22 2001-02-01 Warner-Lambert Company Pullulan film compositions
EP1157691A1 (en) * 2000-05-16 2001-11-28 Warner-Lambert Company Pullulan film compositions with improved surface properties
US6340473B1 (en) 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
WO2003090725A1 (en) * 2002-04-24 2003-11-06 Warner-Lambert Company Llc Capsule preparation
WO2005084649A1 (en) * 2004-03-04 2005-09-15 Takeda Pharmaceutical Company Limited Stable capsule preparation
WO2005120490A1 (en) * 2004-06-11 2005-12-22 Ono Pharmaceutical Co., Ltd. Capsule stable against mastication
JPWO2004096283A1 (en) * 2003-05-02 2006-07-13 株式会社林原生物化学研究所 Soft capsule film and soft capsule
JP2006328038A (en) * 2004-07-30 2006-12-07 Wakunaga Pharmaceut Co Ltd Composition for capsule film, capsule film, capsular preparation using the same, and method for producing the capsular preparation
WO2007149276A2 (en) * 2006-06-16 2007-12-27 Tate & Lyle Ingredients Americas, Inc. Pullulan films and their use in edible packaging
US8029821B2 (en) 2003-12-25 2011-10-04 Shin-Etsu Chemical Co. Ltd. Capsule comprising low-substituted cellulose ether and method for preparing the same
WO2012095746A2 (en) 2011-01-11 2012-07-19 Capsugel Belgium Nv New hard capsules
CN103877067A (en) * 2014-03-31 2014-06-25 江苏力凡胶囊有限公司 Empty capsule capable of controlling disintegration time limit, and preparation method thereof
CN108721632A (en) * 2018-06-27 2018-11-02 中国海洋大学 A kind of high molecular weight pullulan additive and its application in capsule preparation
CN110179766A (en) * 2019-06-14 2019-08-30 江苏力凡胶囊有限公司 A kind of anti-oxidant gelatin soft capsule
CN112891316A (en) * 2021-02-01 2021-06-04 吉林万通药业有限公司 Vitamin E soft capsule and preparation method thereof
US11319566B2 (en) 2017-04-14 2022-05-03 Capsugel Belgium Nv Process for making pullulan
US11576870B2 (en) 2017-04-14 2023-02-14 Capsugel Belgium Nv Pullulan capsules

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050095A1 (en) * 1999-02-26 2000-08-31 Warner-Lambert Company Bioadhesive antibacterial wound healing composition
US6329343B1 (en) 1999-02-26 2001-12-11 Warner-Lambert Company Bioadhesive antibacterial wound healing composition
US6340473B1 (en) 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
USRE39079E1 (en) * 1999-07-07 2006-04-25 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US6582727B2 (en) 1999-07-07 2003-06-24 R. P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US7267718B2 (en) 1999-07-22 2007-09-11 Warner-Lambert Company, Llc Pullulan film compositions
US6887307B1 (en) 1999-07-22 2005-05-03 Warner-Lambert Company, Llc Pullulan film compositions
WO2001007507A1 (en) * 1999-07-22 2001-02-01 Warner-Lambert Company Pullulan film compositions
EP1072633A1 (en) * 1999-07-22 2001-01-31 Warner-Lambert Company Pullulan film compositions
EP1157691A1 (en) * 2000-05-16 2001-11-28 Warner-Lambert Company Pullulan film compositions with improved surface properties
WO2003090725A1 (en) * 2002-04-24 2003-11-06 Warner-Lambert Company Llc Capsule preparation
CN1306931C (en) * 2002-04-24 2007-03-28 沃尼尔·朗伯有限责任公司 Capsule preparation
JPWO2004096283A1 (en) * 2003-05-02 2006-07-13 株式会社林原生物化学研究所 Soft capsule film and soft capsule
US8784883B2 (en) 2003-12-25 2014-07-22 Shin-Etsu Chemical Co., Ltd. Capsule comprising low-substituted cellulose ether and method for preparing the same
US8029821B2 (en) 2003-12-25 2011-10-04 Shin-Etsu Chemical Co. Ltd. Capsule comprising low-substituted cellulose ether and method for preparing the same
JPWO2005084649A1 (en) * 2004-03-04 2007-11-29 武田薬品工業株式会社 Stable capsule
WO2005084649A1 (en) * 2004-03-04 2005-09-15 Takeda Pharmaceutical Company Limited Stable capsule preparation
JP5615478B2 (en) * 2004-06-11 2014-10-29 小野薬品工業株式会社 Stable capsule against chewing
WO2005120490A1 (en) * 2004-06-11 2005-12-22 Ono Pharmaceutical Co., Ltd. Capsule stable against mastication
JP2006328038A (en) * 2004-07-30 2006-12-07 Wakunaga Pharmaceut Co Ltd Composition for capsule film, capsule film, capsular preparation using the same, and method for producing the capsular preparation
JP2006328044A (en) * 2004-07-30 2006-12-07 Wakunaga Pharmaceut Co Ltd Composition for gelatin film, composition for capsule film, capsule film, capsular preparation using the same, and method for producing the capsular preparation
WO2007149276A3 (en) * 2006-06-16 2008-04-03 Tate & Lyle Ingredients Pullulan films and their use in edible packaging
WO2007149276A2 (en) * 2006-06-16 2007-12-27 Tate & Lyle Ingredients Americas, Inc. Pullulan films and their use in edible packaging
WO2012095746A2 (en) 2011-01-11 2012-07-19 Capsugel Belgium Nv New hard capsules
US10130587B2 (en) 2011-01-11 2018-11-20 Capsugel Belgium Nv Hard capsules
US10568839B2 (en) 2011-01-11 2020-02-25 Capsugel Belgium Nv Hard capsules
CN103877067A (en) * 2014-03-31 2014-06-25 江苏力凡胶囊有限公司 Empty capsule capable of controlling disintegration time limit, and preparation method thereof
US11319566B2 (en) 2017-04-14 2022-05-03 Capsugel Belgium Nv Process for making pullulan
US11576870B2 (en) 2017-04-14 2023-02-14 Capsugel Belgium Nv Pullulan capsules
US11878079B2 (en) 2017-04-14 2024-01-23 Capsugel Belgium Nv Pullulan capsules
CN108721632A (en) * 2018-06-27 2018-11-02 中国海洋大学 A kind of high molecular weight pullulan additive and its application in capsule preparation
CN110179766A (en) * 2019-06-14 2019-08-30 江苏力凡胶囊有限公司 A kind of anti-oxidant gelatin soft capsule
CN112891316A (en) * 2021-02-01 2021-06-04 吉林万通药业有限公司 Vitamin E soft capsule and preparation method thereof

Similar Documents

Publication Publication Date Title
JPH0565222A (en) Film containing pullulan blended therein for capsule and capsule
JP4065691B2 (en) Pullulan film composition
JP5357910B2 (en) Soft capsule film and soft capsule
KR100240528B1 (en) Seamless capsule and process for producing the same
JP4294862B2 (en) Gelatin composition
JP3947003B2 (en) Film-forming composition containing modified starch and iota-carrageenan and method for producing soft capsules using the same
JP5731697B2 (en) Soft capsule film and soft capsule
JP4461310B2 (en) Gelatin solids
JPH08208458A (en) Coating film composition for capsule
JP2007536308A (en) Improved pullulan capsule
TW200911358A (en) Seamless capsule
JP4648260B2 (en) Gel-like seasoning in a container and method for producing the same
JP2005137935A (en) Hard capsule and its production method
JP2017165777A (en) Capsule comprising emulsified syrup and method of making the same
JP2000044465A (en) Soft capsule agent
KR101725311B1 (en) Water-soluble hydrogel pads composite of the ultrasonic inspection purposes and its production method
TWI326596B (en)
JPS5939834A (en) Film composition for pharmaceutical
JPS5931711A (en) Pge composition wrapped with acid isolation gelatin
JP4441716B2 (en) Soft capsule
JPH05245366A (en) Seamless capsule having water-insoluble film in inner side face and its production
TW201924543A (en) Edible film carrying lutein and preparation method thereof which is convenient to carry for eating at any time and can maintain the activity of lutein for a long period of time
JPH0353873A (en) Soft capsule
JP2018062495A (en) Capsule coating composition and capsule
KR0185037B1 (en) A tube type softcapsule containing vermifuge

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 19981203